董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Lynn A. Tetrault | 女 | Chairman of the Board | 62 | 15.77万美元 | 未持股 | 2025-08-05 |
| Alison L. Hannah | 女 | Independent Director | 64 | 13.77万美元 | 未持股 | 2025-08-05 |
| Anthony P. Zook | -- | Director and Chief Executive Officer | -- | 未披露 | 未持股 | 2025-08-05 |
| Felicia Williams | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-05 |
| Stephen M. Kanovsky | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-05 |
| Michael A. Kelly | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-05 |
| David B. Perez | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-05 |
| Neil Gunn | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-05 |
| Marjorie C. Green | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-05 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Anthony P. Zook | -- | Director and Chief Executive Officer | -- | 未披露 | 未持股 | 2025-08-05 |
| Cynthia J. Dieter | -- | Chief Accounting Officer and Controller | -- | 未披露 | 未持股 | 2025-08-05 |
| Warren C. Stone | -- | President and Chief Operating Officer | -- | 未披露 | 未持股 | 2025-08-05 |
| Jeffrey S. Sherman | -- | Chief Financial Officer | -- | 未披露 | 未持股 | 2025-08-05 |
| Gregory D. Aunan | -- | Chief Accounting Officer and Senior Vice President | -- | 未披露 | 未持股 | 2025-08-05 |
| Beth Eastland | -- | Senior Vice President, Enterprise Sales | -- | 未披露 | 未持股 | 2025-08-05 |
| Alicia C. Olivo | -- | Executive Vice President, Business Development, General Counsel and Corporate Secretary | -- | 未披露 | 未持股 | 2025-08-05 |
董事简历
中英对照 | 中文 | 英文- Lynn A. Tetrault
-
Lynn A. Tetrault， 2015年6月起担任董事。她目前是顾问。1993-2014年，在AstraZeneca, PLC工作；最近担任人力资源和企业事务执行副总裁。她负责该公司所有的人力资源战略，人才管理，高管薪酬和相关的活动，内部和外部沟通，政府事务，企业信誉和企业的社会责任。她是Princeton大学的本科生；以及是Virginia 大学法学院的法学博士学位。目前是Womens’ Way的董事。
Lynn A. Tetrault has served as a director since June 2015. Mrs. Tetrault is currently a consultant. She worked from 1993 to 2014 with AstraZeneca, PLC most recently as Executive Vice President Human Resources and Corporate Affairs. Mrs. Tetrault was responsible for all human resources strategy, talent management, executive compensation and related activities, internal and external communications, government affairs, corporate reputation and corporate social responsibility for the Company. Mrs. Tetrault has an undergraduate degree from Princeton University and a J.D. from the University of Virginia Law School. - Lynn A. Tetrault， 2015年6月起担任董事。她目前是顾问。1993-2014年，在AstraZeneca, PLC工作；最近担任人力资源和企业事务执行副总裁。她负责该公司所有的人力资源战略，人才管理，高管薪酬和相关的活动，内部和外部沟通，政府事务，企业信誉和企业的社会责任。她是Princeton大学的本科生；以及是Virginia 大学法学院的法学博士学位。目前是Womens’ Way的董事。
- Lynn A. Tetrault has served as a director since June 2015. Mrs. Tetrault is currently a consultant. She worked from 1993 to 2014 with AstraZeneca, PLC most recently as Executive Vice President Human Resources and Corporate Affairs. Mrs. Tetrault was responsible for all human resources strategy, talent management, executive compensation and related activities, internal and external communications, government affairs, corporate reputation and corporate social responsibility for the Company. Mrs. Tetrault has an undergraduate degree from Princeton University and a J.D. from the University of Virginia Law School.
- Alison L. Hannah
-
Alison L. Hannah， 2015年6月起担任董事。她有超过25年的研究性癌症化疗发展经验。2000年起在医药行业担任顾问，为20多家公司服务，专注于分子靶向治疗。此前，在SUGEN 担任高级医疗总监，从事各种化合物，包括肾癌批准药物Sutent；以及在Quintiles（一家全球性合同研究组织）。她专注于临床发展战略，已经为新分子实体和7个新药提交了30新药研究申请。她参与了数据监控委员会，科学咨询委员会和独立审查委员会，进行临床试验。持有哈佛大学的生物化学和免疫学学士学位，以及Saint Andrews大学的医学位。是ASCO, AACR, ASH, ESMO的成员，以及是英国皇家医学会的一名院士。
Alison L. Hannah has served as a director since June 2015. Dr. Hannah has over 25 years'experience in the development of investigational cancer chemotherapies. Since 2000 she has served as a consultant to the pharmaceutical industry, working with over 20 companies with a focus on molecularly targeted therapy. Prior to this, she worked as Senior Medical Director at SUGEN on various compounds, including Sutent approved in kidney cancer, and Quintiles, a global Contract Research Organization. Dr. Hannah specializes in clinical development strategy, and has filed over 30 Investigational New Drug applications for new molecular entities and 7 New Drug Applications. She participates in Data Monitoring Committees, Scientific Advisory Boards and Independent Review Committees for clinical trials. She has a bachelor's degree in biochemistry and immunology from Harvard University and her medical degree from the University of Saint Andrews. She is a member of ASCO, AACR, ASH, ESMO and a Fellow with the Royal Society of Medicine. - Alison L. Hannah， 2015年6月起担任董事。她有超过25年的研究性癌症化疗发展经验。2000年起在医药行业担任顾问，为20多家公司服务，专注于分子靶向治疗。此前，在SUGEN 担任高级医疗总监，从事各种化合物，包括肾癌批准药物Sutent；以及在Quintiles（一家全球性合同研究组织）。她专注于临床发展战略，已经为新分子实体和7个新药提交了30新药研究申请。她参与了数据监控委员会，科学咨询委员会和独立审查委员会，进行临床试验。持有哈佛大学的生物化学和免疫学学士学位，以及Saint Andrews大学的医学位。是ASCO, AACR, ASH, ESMO的成员，以及是英国皇家医学会的一名院士。
- Alison L. Hannah has served as a director since June 2015. Dr. Hannah has over 25 years'experience in the development of investigational cancer chemotherapies. Since 2000 she has served as a consultant to the pharmaceutical industry, working with over 20 companies with a focus on molecularly targeted therapy. Prior to this, she worked as Senior Medical Director at SUGEN on various compounds, including Sutent approved in kidney cancer, and Quintiles, a global Contract Research Organization. Dr. Hannah specializes in clinical development strategy, and has filed over 30 Investigational New Drug applications for new molecular entities and 7 New Drug Applications. She participates in Data Monitoring Committees, Scientific Advisory Boards and Independent Review Committees for clinical trials. She has a bachelor's degree in biochemistry and immunology from Harvard University and her medical degree from the University of Saint Andrews. She is a member of ASCO, AACR, ASH, ESMO and a Fellow with the Royal Society of Medicine.
- Anthony P. Zook
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Felicia Williams
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Stephen M. Kanovsky
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Michael A. Kelly
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- David B. Perez
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Neil Gunn
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Marjorie C. Green
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
高管简历
中英对照 | 中文 | 英文- Anthony P. Zook
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Cynthia J. Dieter
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Warren C. Stone
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Jeffrey S. Sherman
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Gregory D. Aunan
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Beth Eastland
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Alicia C. Olivo
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介